Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
12226
CALL
VEON
VEON
$5.26B
| $56.1K | ﹤0.01% |
1,400
-2,700
| -66% | -$89.6K |
2023 Q4
4 quarters
|
|
12227
CALL
Expro Ltd
XPRO
$1.82B
| $56.1K | ﹤0.01% |
4,500
-3,700
| -45% | -$51.6K |
2022 Q4
8 quarters
|
|
12228
PUT
Heartland Express
HTLD
$876M
| $56.1K | ﹤0.01% |
5,000
+900
| +22% | +$10.6K |
2021 Q2
14 quarters
|
|
12229
T-REX 2X Long Tesla Daily Target ETF
TSLT
$164M
| $56.1K | ﹤0.01% |
1,480
-152,916
| -99% | -$4.14M |
2024 Q3
1 quarter
|
|
12230
PUT
Eve Holding
EVEX
$596M
| $56K | ﹤0.01% |
10,300
+10,200
| +10,200% | +$38.3K |
2024 Q2
2 quarters
|
|
12231
PUT
Alector
ALEC
$202M
| $55.9K | ﹤0.01% |
29,600
+24,900
| +530% | +$93.7K |
2022 Q4
8 quarters
|
|
12232
PUT
Eton Pharmaceutcials
ETON
$1.57B
| $55.9K | ﹤0.01% |
4,200
+3,700
| +740% | +$37.5K |
2024 Q2
2 quarters
|
|
12233
Mind CTI
MNDO
$19.8M
| $55.9K | ﹤0.01% |
28,394
-13,019
| -31% | -$25.7K |
2022 Q3
9 quarters
|
|
12234
Jack Henry & Associates
JKHY
$10.1B
| $55.9K | ﹤0.01% |
319
-103,723
| -100% | -$18.5M |
2019 Q2
22 quarters
|
|
12235
CALL
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$7.77B
| $55.9K | ﹤0.01% |
+4,300
| New | +$58K |
2024 Q4
0 quarters
|
|
12236
CALL
Enanta Pharmaceuticals
ENTA
$354M
| $55.8K | ﹤0.01% |
9,700
+4,900
| +102% | +$47K |
2021 Q4
12 quarters
|
|
|
ETHD
12237
PUT
ProShares UltraShort Ether ETF
ETHD
$60.2M
| $55.8K | ﹤0.01% |
250
+130
| +108% | +$49.6K |
2024 Q3
1 quarter
|
|
12238
PUT
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.95B
| $55.7K | ﹤0.01% |
+1,200
| New | +$56.7K |
2024 Q4
0 quarters
|
|
12239
CALL
Champions Oncology
CSBR
$69.7M
| $55.7K | ﹤0.01% |
+6,500
| New | +$32.7K |
2024 Q4
0 quarters
|
|
12240
CALL
ProQR Therapeutics
PRQR
$233M
| $55.6K | ﹤0.01% |
21,000
+20,700
| +6,900% | +$65.7K |
2023 Q4
4 quarters
|
|
12241
CALL
Afya
AFYA
$1.23B
| $55.6K | ﹤0.01% |
3,500
+1,400
| +67% | +$23.1K |
2024 Q1
3 quarters
|
|
12242
CALL
Aware
AWRE
$23.3M
| $55.6K | ﹤0.01% |
28,500
+26,000
| +1,040% | +$44.3K |
2024 Q1
3 quarters
|
|
12243
CALL
TXO Partners LP
TXO
$771M
| $55.6K | ﹤0.01% |
3,300
+300
| +10% | +$5.45K |
2024 Q3
1 quarter
|
|
12244
CALL
Kite Realty
KRG
$4.83B
| $55.5K | ﹤0.01% |
2,200
-11,100
| -83% | -$292K |
2021 Q1
15 quarters
|
|
12245
CALL
MasterBrand
MBC
$1.44B
| $55.5K | ﹤0.01% |
3,800
-13,000
| -77% | -$222K |
2023 Q1
7 quarters
|
|
12246
Siebert Financial
SIEB
$91.2M
| $55.5K | ﹤0.01% |
17,565
+13,690
| +353% | +$37.1K |
2024 Q1
3 quarters
|
|
12247
PUT
Fulcrum Therapeutics
FULC
$282M
| $55.5K | ﹤0.01% |
11,800
-190,400
| -94% | -$702K |
2021 Q3
13 quarters
|
|
12248
CALL
ALX Oncology
ALXO
$153M
| $55.4K | ﹤0.01% |
33,200
-38,400
| -54% | -$59K |
2021 Q1
15 quarters
|
|
|
TBNK
12249
DELISTED
Territorial Bancorp Inc.
TBNK
| $55.4K | ﹤0.01% |
5,692
-2,998
| -34% | -$31.6K |
2024 Q2
2 quarters
|
|
12250
PUT
Amplify Seymour Cannabis ETF
CNBS
$70.4M
| $55.4K | ﹤0.01% |
2,250
-75
| -3% | -$3.27K |
2024 Q3
1 quarter
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.